Stonepine Capital Management, LLC
Position in KTTA — Pasithea Therapeutics Corp.
CIK 1440771
BEND, OR
Position in KTTA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$616,825
+$261,996 QoQ
Shares Held
831,301
+202.2% QoQ
Ownership
2.49%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KTTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Stonepine Capital Management, LLC holds $96,227,473 across 56 Biotechnology names. KTTA ranks #28 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VSTM |
Verastem, Inc.
|
3,302,300 | $17,502,190 | |
| 2 | TENX |
Tenax Therapeutics, Inc.
|
975,200 | $15,593,448 | |
| 3 | ADMA |
Adma Biologics, Inc.
|
740,000 | $6,667,400 | |
| 4 | CAMP |
Camp4 Therapeutics Corp
|
1,389,622 | $6,128,233 | |
| 5 | NKTR |
Nektar Therapeutics
|
85,000 | $6,115,750 | |
| 6 | ZVRA |
Zevra Therapeutics, Inc.
|
480,000 | $4,473,600 | |
| 7 | CRBP |
Corbus Pharmaceuticals Holdings, Inc.
|
383,462 | $3,600,708 | |
| 8 | ABEO |
Abeona Therapeutics Inc.
|
746,587 | $3,344,709 |
All Filings in KTTA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-17 | $980,180 | 1,952,550 | Shares | Sole | 2026-06-23 | |
| 2026-03-31 | $616,825 | 831,301 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $354,829 | 275,062 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||